INACTIVATION OF SELECTED NIAID PROGRAM ANNOUNCEMENTS Release Date: October 16, 1998 P.T. National Institute of Allergy and Infectious Diseases The National Institute of Allergy and Infectious Diseases (NIAID) is inactivating its sponsorship of two Program Announcements (PAs). NIAID will not give special consideration for funding to applications in response these PAs received after February 1, 1999. NIAID regularly reviews its portfolio of active program announcements. When the objectives of PAs have been attained, NIAID announces inactivation of those PAs. NIAID supports highly scientifically meritorious applications in all areas of research within its mission, including the scientific areas delineated in these PAs. PA inactivation simply means that special consideration for funding beyond normal paylines will NO LONGER be given to applications on the research topics identified in the inactivated PAs. However, such applications will be accepted, reviewed, and considered for funding with all other investigator-initiated applications. At any time, potential applicants can obtain a current listing of active NIAID PAs on the NIAID WWW site at URL: http://www.niaid.nih.gov/ncn/pa-table.htm The PAs being inactivated are: PA-97-026, Aspergillosis, Ehrlichioses and Drug Resistance, NIH Guide, January 31, 1997 PA-98-039, Modern Vaccines for Mycoses, NIH Guide, March 6, 1998 INQUIRIES For questions or further information, contact: Office of the Director Division of Extramural Activities National Institute of Allergy and Infectious Diseases Solar Building, Room 3C20 Bethesda, MD 20892-7610 Telephone: (301) 496-7291 FAX: (301) 402-0369 Email: ac20a@nih.gov
Return to NIH Guide Main Index
Office of Extramural Research (OER) |
National Institutes of Health (NIH) 9000 Rockville Pike Bethesda, Maryland 20892 |
Department of Health and Human Services (HHS) |
||||||||
Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files. |